0001237899-11-000077.txt : 20111220
0001237899-11-000077.hdr.sgml : 20111220
20111220154426
ACCESSION NUMBER: 0001237899-11-000077
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20111216
FILED AS OF DATE: 20111220
DATE AS OF CHANGE: 20111220
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER RD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591-6707
BUSINESS PHONE: 9143477000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Powchik Peter
CENTRAL INDEX KEY: 0001377247
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 111272025
MAIL ADDRESS:
STREET 1: REGENERON PHARMACEUTICALS, INC.
STREET 2: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0304
4
2011-12-16
0
0000872589
REGENERON PHARMACEUTICALS INC
REGN
0001377247
Powchik Peter
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
SVP Clinical Development & Reg
Incentive Stock Option (right to buy)
52.03
2011-12-16
4
A
0
1921
A
2021-12-16
Common Stock
1921
1921
D
Non-Qualified Stock Option (right to buy)
16.8
2011-12-16
4
A
0
30000
A
2011-12-17
2018-12-17
Common Stock
30000
45000
D
Non-Qualified Stock Option (right to buy)
52.03
2011-12-16
4
A
0
30079
A
2021-12-16
Common Stock
30079
30079
D
The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.
On December 17, 2008, the reporting person was granted an option to purchase 30,000 shares of Common Stock. The option vests, partially or in full, on December 31, 2011, based on the extent to which the company satisfies certain performance criteria during the period ending December 31, 2011. The performance criteria have been met and the option will vest as to all 30,000 shares on December 31, 2011.
/s/**Peter Powchik
2011-12-20